Status:
COMPLETED
Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy
Lead Sponsor:
GlaxoSmithKline
Conditions:
Epilepsy
Eligibility:
All Genders
18-50 years
Brief Summary
Validation of qolie-10, an epilepsy specific quality of life questionnaire in patients treated with lamotrigine or valproic acid. Comparison of quality of life of epileptic patients treated with lamot...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Diagnosis of epilepsy and normal neurological examination.
- Patients receiving lamotrigine or valproic acid at stable doses in monotherapy initiated 2 -4 months before.
- Exclusion criteria:
- Pregnant or lactating women.
- Previous treatment with lamotrigine or valproic acid.
- Secondary epilepsy.
Exclusion
Key Trial Info
Start Date :
October 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
333 Patients enrolled
Trial Details
Trial ID
NCT00264680
Start Date
October 1 2003
End Date
March 1 2006
Last Update
October 30 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.